The Impact of Diabetes Counseling and Education Clinical and Cost Outcomes From a Large Population of US Managed Care Patients With Type 2 Diabetes

被引:6
|
作者
Sullivan, Sean D. [1 ]
Dalal, Mehul R. [2 ]
Burke, James P. [3 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Sanofi US Inc, Bridgewater, NJ USA
[3] OPTUM Insight, Eden Prairie, MN USA
来源
DIABETES EDUCATOR | 2013年 / 39卷 / 04期
关键词
IMPROVED GLYCEMIC CONTROL; SELF-MANAGEMENT; GLUCOSE CONTROL; MELLITUS; ADULTS; METAANALYSIS; HEMOGLOBIN; BENEFITS;
D O I
10.1177/0145721713486525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The purpose of this study is to examine outcomes in adult patients with type 2 diabetes mellitus who received diabetes counseling and education (C/E) services compared with those who did not. Methods A matched, retrospective cohort study of 17 483 C/E recipients and 17 470 non-C/E controls was followed for up to 12 months. Outcomes included glycemic control (glycosylated hemoglobin A1C levels <7.0%), hypoglycemic events, and health care utilization and costs. Results Compared with the non-C/E group, patients in the C/E group had significantly lower A1C (7.7% vs 7.2%) and were more likely to achieve glycemic control at 6 months' follow-up; they were also more likely to have a hypoglycemic event. During the 1-year period following the index date, C/E recipients had more inpatient visits (0.21 vs 0.20 visits per patient) and ambulatory visits (21.5 vs 18.6 visits per patient) compared with non-C/E controls. The increased use of health care services in the C/E groups was associated with $2388 higher annual overall costs and $827 higher diabetes-related costs. Conclusions Diabetes C/E is associated with improved glycemic control, albeit with a slight increase in the risk of hypoglycemia. C/E was associated with higher health care costs across 12 months. Further analyses are needed to evaluate long-term cost-effectiveness of diabetes counseling and education.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [1] Impact of Diabetes Counseling and Education on Diabetes Clinical and Cost Outcomes
    Sullivan, Sean D.
    Dalal, Mehul
    Burke, James
    DIABETES, 2011, 60 : A64 - A64
  • [2] Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large US Managed Care Population
    Grabner, Michael
    Peng, Xiaomei
    Geremakis, Caroline
    Bae, Jay
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (12): : 1204 - +
  • [3] Education for Diabetes (EDDI) programme: Impact on diabetes control in patients with Type 2 diabetes from an ethnically diverse population
    Marples, O.
    Alam, F.
    Mallik, R.
    Medici, F.
    DIABETIC MEDICINE, 2019, 36 : 29 - 29
  • [4] Clinical Inertia in Patients with Type 2 Diabetes at a Large, Integrated, US Health Care System
    Petruso, Holly
    Ejzykowicz, Flavia
    Gohs, Frank
    Mahabaleshwarkar, Rohan
    Desantis, Andrea
    Wilkins, Nick
    Templin, Megan
    Rajpathak, Swapnil
    Norton, James
    DIABETES, 2016, 65 : A377 - A377
  • [5] HEALTH CARE COSTS AND RESOURCE UTILIZATION OF PATIENTS WITH TYPE 2 DIABETES MELLITUS WITHIN A NATIONAL US MANAGED CARE POPULATION
    Burke, J. P.
    Parker, M.
    Sander, S.
    Moran, H. J.
    Thayer, S.
    VALUE IN HEALTH, 2010, 13 (03) : A58 - A58
  • [6] Clinical characteristics and outcomes in patients with type 2 diabetes adding insulin glargine to exenatide or exenatide to insulin glargine in a US managed care setting
    Levin, P.
    Wei, W.
    Wang, L.
    Baser, O.
    DIABETOLOGIA, 2011, 54 : S419 - S419
  • [7] Nutritional Recommendations for Type 2 Diabetes For Diabetes Counseling and -Education
    Fiederling, Ute
    ERNAHRUNGS UMSCHAU, 2019, 66 (09): : M562 - M563
  • [8] Modeling the clinical benefits of inhaled in managed care patients with type 2 diabetes mellitus
    Vishalpura, Tejal
    Harnett, Jim
    Kruep, Eric
    DIABETES, 2007, 56 : A656 - A656
  • [9] Thiazolidinediones in the treatment of managed care patients with type 2 diabetes
    Pathak, R
    Afaq, A
    Blonde, L
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (16): : S483 - S494
  • [10] Cost and Frequency of Blood Glucose Self-Monitoring in Type 2 Diabetes Patients Treated with Insulin in US Managed Care
    Martin, Alan A.
    Changolkar, Arun
    Arondekar, Bhakti
    DIABETES, 2011, 60 : A629 - A629